ORIC — Oric Pharmaceuticals Inc

Ownership history in Campbell & CO Investment Adviser LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which Campbell & CO Investment Adviser LLC reported a position in Oric Pharmaceuticals Inc (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.11% (2024 Q1)
Avg. % of fund
0.04%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 13,970 -5,698 -29.0% 0.01% $168K $12.00
2025 Q2 REDUCED 19,668 -7,573 -27.8% 0.01% $200K $10.15
2024 Q3 REDUCED 27,241 -69,227 -71.8% 0.02% $279K $10.25
2024 Q1 ADDED 96,468 +58,849 +156.4% 0.11% $1.3M $13.75
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ORIC price (monthly, adj. close)

Other funds also holding ORIC

As of 2025 Q4 — sorted by position size

Column Group LLC 3Y 34.98% PFIZER INC 18.6% SR ONE CAPITAL MANAGEMENT, LP 3Y 5.34% EcoR1 Capital, LLC 3Y 7Y 2.5% VR Adviser, LLC 3Y 2.29% Euclidean Capital LLC 3Y 2.19% First Turn Management, LLC 1.88% NEA Management Company, LLC 3Y 7Y 1.72% MPM BioImpact LLC 3Y 1.68% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.59%
← Back to Campbell & CO Investment Adviser LLC Holdings